Advanced search
1 file | 377.86 KB Add to list

Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study

Wim Ceelen (UGent) , Louis Sandra (UGent) , Leen Van de Sande, Martin Graversen, An Vermeulen (UGent) , Dries Reynders (UGent) , Sarah Cosyns (UGent) , Anne Hoorens (UGent) and Wouter Willaert (UGent)
(2021) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 39(Supplement 15). p.4065-4065
Author
Organization
Keywords
Cancer Research, Oncology

Downloads

  • 2020 ASCO PTX.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 377.86 KB

Citation

Please use this url to cite or link to this publication:

MLA
Ceelen, Wim, et al. “Intraperitoneal Aerosolized Nanoparticle Albumin Based Paclitaxel (NAB-PTX) for Irresectable Peritoneal Metastases : A First in Human Phase I Study.” JOURNAL OF CLINICAL ONCOLOGY, vol. 39, no. Supplement 15, 2021, pp. 4065–4065, doi:10.1200/jco.2021.39.15_suppl.4065.
APA
Ceelen, W., Sandra, L., Van de Sande, L., Graversen, M., Vermeulen, A., Reynders, D., … Willaert, W. (2021). Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study. JOURNAL OF CLINICAL ONCOLOGY, 39(Supplement 15), 4065–4065. https://doi.org/10.1200/jco.2021.39.15_suppl.4065
Chicago author-date
Ceelen, Wim, Louis Sandra, Leen Van de Sande, Martin Graversen, An Vermeulen, Dries Reynders, Sarah Cosyns, Anne Hoorens, and Wouter Willaert. 2021. “Intraperitoneal Aerosolized Nanoparticle Albumin Based Paclitaxel (NAB-PTX) for Irresectable Peritoneal Metastases : A First in Human Phase I Study.” In JOURNAL OF CLINICAL ONCOLOGY, 39:4065–4065. https://doi.org/10.1200/jco.2021.39.15_suppl.4065.
Chicago author-date (all authors)
Ceelen, Wim, Louis Sandra, Leen Van de Sande, Martin Graversen, An Vermeulen, Dries Reynders, Sarah Cosyns, Anne Hoorens, and Wouter Willaert. 2021. “Intraperitoneal Aerosolized Nanoparticle Albumin Based Paclitaxel (NAB-PTX) for Irresectable Peritoneal Metastases : A First in Human Phase I Study.” In JOURNAL OF CLINICAL ONCOLOGY, 39:4065–4065. doi:10.1200/jco.2021.39.15_suppl.4065.
Vancouver
1.
Ceelen W, Sandra L, Van de Sande L, Graversen M, Vermeulen A, Reynders D, et al. Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study. In: JOURNAL OF CLINICAL ONCOLOGY. 2021. p. 4065–4065.
IEEE
[1]
W. Ceelen et al., “Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study,” in JOURNAL OF CLINICAL ONCOLOGY, Online, 2021, vol. 39, no. Supplement 15, pp. 4065–4065.
@inproceedings{8710630,
  author       = {{Ceelen, Wim and Sandra, Louis and Van de Sande, Leen and Graversen, Martin and Vermeulen, An and Reynders, Dries and Cosyns, Sarah and Hoorens, Anne and Willaert, Wouter}},
  booktitle    = {{JOURNAL OF CLINICAL ONCOLOGY}},
  issn         = {{0732-183X}},
  keywords     = {{Cancer Research,Oncology}},
  language     = {{eng}},
  location     = {{Online}},
  number       = {{Supplement 15}},
  pages        = {{4065--4065}},
  title        = {{Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study}},
  url          = {{http://doi.org/10.1200/jco.2021.39.15_suppl.4065}},
  volume       = {{39}},
  year         = {{2021}},
}

Altmetric
View in Altmetric